To substantiate the importance of HDAC2 in CRC drug resistance, exogenous WT P53 was transfected into HT-29 cells and into HT-29-ShRNA-HDAC2 cells followed by Oxa treatment (Figure 4C). This evidence concerns the gene TP53 and colorectal carcinoma.